Application Information

This drug has been submitted to the FDA under the reference 021640/001.

Names and composition

"VITRASE" is the commercial name of a drug composed of HYALURONIDASE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021640/001 VITRASE HYALURONIDASE INJECTABLE/INJECTION 6,200 UNITS per VIAL
021640/002 VITRASE HYALURONIDASE INJECTABLE/INJECTION 200 UNITS per VIAL

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
006343/002 WYDASE HYALURONIDASE INJECTABLE/INJECTION 150 UNITS per ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
006343/005 WYDASE HYALURONIDASE INJECTABLE/INJECTION 1,500 UNITS per VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
006343/006 WYDASE HYALURONIDASE INJECTABLE/INJECTION 150 UNITS per VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
021640/001 VITRASE HYALURONIDASE INJECTABLE/INJECTION 6,200 UNITS per VIAL
021640/002 VITRASE HYALURONIDASE INJECTABLE/INJECTION 200 UNITS per VIAL
021665/001 AMPHADASE HYALURONIDASE INJECTABLE/INJECTION 150 UNITS per ML
021716/001 HYDASE HYALURONIDASE INJECTABLE/INJECTION 150 UNITS per ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved